Allogene Therapeutics ALLO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.46 | -0.28 | -65,191 | -60 | ||
| 2024Q4 | 2.13 | 101.81 | -0.28 | -60,490 | -60 | |
| 2024Q3 | 2.80 | 108.43 | -0.31 | -71,774 | -66 | |
| 2024Q2 | 2.33 | 107.64 | -0.35 | -71,431 | -66 | |
| 2024Q1 | 4.47 | 106.93 | -0.38 | -69,504 | -65 | |
| 2023Q4 | 3.21 | 99.22 | -0.51 | -85,109 | -86 | |
| 2023Q3 | 3.17 | 107.01 | -0.35 | -62,931 | -59 | |
| 2023Q2 | 4.97 | 101.65 | -0.54 | -80,540 | -79 | |
| 2023Q1 | 4.94 | 99.12 | -0.69 | -99,092 | -100 | |
| 2022Q4 | 6.29 | 101.61 | -0.65 | -96,374 | -95 | |
| 2022Q3 | 10.80 | 99.21 | -0.58 | -82,489 | -83 | |
| 2022Q2 | 11.40 | 102.42 | -0.53 | -76,594 | -75 | |
| 2022Q1 | 9.11 | 100.18 | -0.56 | -79,992 | -80 | |
| 2021Q4 | 14.92 | 98.70 | 0.01 | -73,893 | -75 | |
| 2021Q3 | 25.70 | 99.34 | -0.57 | -77,669 | -78 | |
| 2021Q2 | 26.08 | 100.13 | -0.53 | -71,029 | -71 | |
| 2021Q1 | 35.30 | 100.56 | -0.25 | -33,201 | -33 | |
| 2020Q4 | 25.24 | 101.16 | -0.53 | -69,362 | -69 | |
| 2020Q3 | 37.71 | 102.79 | -0.52 | -68,042 | -66 | |
| 2020Q2 | 42.82 | 103.58 | -0.53 | -63,156 | -61 |